Just finished my keynote at @conference_2021 on "Mental health: studying systems instead of syndromes". You can find slides & new preprint here: osf.io/bm6r5/. Really enjoyed making a completely new presentation from scratch.

🧵
The first barrier to progress I talk about is diagnostic literalism and its consequences: while many of us don't believe in MDD or schizophrenia as "natural disease units" in the world, case-control research in our field is often carried out in that way.
I discuss some historical evidence on how arbitrary many of the categories and thresholds we have today in DSM-5 were, and that DSM-5 may look quite different today if minor things had gone differently.

This means diagnostic categories are not natural kinds.
But our field is not alone in having failed its ambitious mission to identify natural kinds: many nosologies are somewhat arbitrary (e.g. biological species, emotions, threshold for high blood pressure). That doesn't make these things less "real" or important.
The second barrier I talk about is reductionism, using the prominent example of biological reductionism. Reductionism is a useful heuristic tool, but has limited value in complex systems such as mental disorders.
Both barriers interact with each other in a vicious cycle: somewhat arbitrary diagnostic categories are reified because we identify (e.g. biological) correlates.
Moving forward, conceptualizing and studying mental disorders as complex systems offer many new opportunities because there is a rich field of complexity science with many theories and methods that may prove to be useful for mental research.
I discuss some features we can study from this perspective, such as emergence, early warning systems, phase transitions, stable states, and so on.

Thanks to @conference_2021 for inviting me to give a keynote; slides osf.io/bm6r5/.

/ 🧵.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Eiko Fried

Eiko Fried Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @EikoFried

22 Jul
There is a broad coalition in 🇳🇱 academia trying to improve the status quo.

Not surprisingly, there were quick responses to a number of recent pieces pushing back against reforms. You can find these rebuttals here. 🧵
1. "Science is NOT like competitive sports."(🇬🇧)
By @YALeiden members & colleagues at @UniLeiden.

voicesyoungacademics.nl/articles/scien…
2. "We need to get rid of numeracy in science."(🇳🇱)
By a coalition of early career scholars. You can sign the document at the bottom.

scienceguide.nl/2021/07/we-moe…
Read 4 tweets
20 Jul
Dutch universities are making a move to abandon the impact factor in recognition and reward considerations. A group of 170 Dutch academics posted a critical response to this initiative. I summarize why these responses fail to convince me. 🧵
First, for context, here the initiative by @UniUtrecht we are talking about: changing rewards and recognitions. Other universities have similar initiatives.

nature.com/articles/d4158…
Here the rebuttal by 171 academics in the Netherlands, most of whom appear to be full professors. It's in NL, but google translate works well for Dutch websites.

scienceguide.nl/2021/07/nieuwe…
Read 17 tweets
19 Apr
1/ National Institute for Health & Care Excellence does not recommend #esketamine to treat #depression bc effectiveness unclear (low quality trials), problematic economic model (short-term treatment, depression lasts long). Cost/benefit not sufficient to recommend treatment.
2/ Here the recommendation (nice.org.uk/consultations/…).

Thanks for @PloederlM for sharing.
3/ Agreed that published literature is low quality. Samples are generally too small to draw inferences from the samples to the population; there are recent studies without placebo groups (how does that even get funded in 2020); when placebo groups exist, they are often not >>
Read 5 tweets
10 Apr
"Hans-Ulrich Wittchen .. is under fire after an investigation into one of his studies found evidence of manipulation—and elaborate efforts to cover up the misdeed. The investigation report .. also shows Wittchen intimidated whistleblowers"

science.sciencemag.org/content/372/65…
(I haven't vetted this, and cannot access the full paywalled article on my phone; just sharing because it may be of interest to others)
April 2019 article about this topic (in German)

sueddeutsche.de/gesundheit/med…
Read 4 tweets
9 Apr
Brief comment on the new "breakthrough study" on #depression blood tests. 🧵

TLDR: there is no blood test for depression.

neurosciencenews.com/depression-bip…
1/ A test helps to determine whether you have a feature or not.

Good tests are precise: they predict a feature well, have high sensitivity/specificity, & low false positives/negatives.
2/ Precise biological tests do not exist for the most common mental disorders. There are some weak biological correlates for depression, but a weak correlate is not a test, the same way that a weak correlate of COVID (coughing) is not a test for COVID.
Read 16 tweets
17 Mar
Happy to share our new preprint with Edwin de Beurs, in which we recommend to solve the current dilemma "So-Many-Scales-For-The-Same-Construct" (e.g. for depression) by mandating a common metric, not by mandating a common measure.🧵

psyarxiv.com/m4qzb/
We introduce the problem of scale proliferation, and how it impacts not only science, but also communication (between researchers & policy makers; between clinicians; between clinicians & clients; etc).
A harmonization proposal is to mandate specific measures (e.g. PHQ9 for depression), introduced by @wellcometrust @NIH @mirandarwolpert.

@pravpatalay & I discuss the challenges of this approach in detail here:

acamh.onlinelibrary.wiley.com/doi/full/10.11…
Read 12 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(